Лучшие больницы для «Vaginismus Treatment» в Мумбаи, Индия

Vaginismus — classified in DSM-5 and ICD-11 under Genito-Pelvic Pain/Penetration Disorder (GPPPD) — is characterized by persistent or recurrent difficulty with vaginal penetration accompanied by involuntary tensioning of the pelvic floor musculature, most critically the levator ani and bulbocavernosus groups. The reflex contraction is mediated by a complex interaction between the somatic nervous system, the autonomic fear-avoidance response, and conditioned psychological associations; it is not a structural anatomical defect. Severity is clinically graded using the Lamont Classification (Grade 1 through 5), with Grade 1 representing spasm only on examination and Grade 5 representing total avoidance of any pelvic contact, allowing clinicians to calibrate treatment intensity objectively.

• ELIGIBLE PATIENTS:
• Women of any age presenting with Grade 1–5 vaginismus per Lamont Classification, including primary (lifelong) and secondary (acquired) subtypes
• Patients with confirmed Genito-Pelvic Pain/Penetration Disorder (GPPPD) per DSM-5 criteria, validated by a licensed gynecologist or psychosexual medicine specialist
• Patients who have not responded to self-directed dilator therapy alone and require supervised, structured clinical programs
• Patients seeking botulinum toxin A (BoNT-A) injection for refractory vaginismus who are medically stable and not pregnant or breastfeeding
• +18 more

TIER 1 — FIRST-LINE BEHAVIORAL AND PHYSIOTHERAPY PROTOCOLS (Non-Pharmacological):

Structured Pelvic Floor Physical Therapy: The cornerstone of vaginismus treatment, delivered by specialist women's health physiotherapists. Techniques include manual internal pelvic floor release (trigger-point therapy targeting the pubococcygeus, iliococcygeus, and obturator internus), connective tissue mobilization, and paradoxical relaxation training. Sessions are typically 45–60 minutes, conducted 2–3 times per week over 4–12 weeks depending on severity grade.

Progressive Vaginal Dilator Therapy: Systematic desensitization using a calibrated set of medical-grade silicone dilators (commonly 6-piece Amielle Comfort® or equivalent sets, progressing from approximately 3 mm to 35 mm diameter). Patients progress through sizes at their own controlled pace under physiotherapist supervision, with homework assignments for daily home practice. The average program spans 6–12 weeks for Grades 1–3 and 12–24 weeks for Grades 4–5.

sEMG Biofeedback-Assisted Relaxation Training: Surface electromyography sensors placed at the perineum or intravaginally (where tolerated) provide real-time visual or auditory feedback of pelvic floor muscle activation levels. Patients learn to consciously identify and down-regulate hypertonicity, achieving resting tone targets below 2 µV. This technology-assisted approach significantly accelerates voluntary muscle control compared to unassisted exercises.

PHASE 1 — PRE-ARRIVAL (4–8 Weeks Before Travel):

• GAF Healthcare assigns a dedicated female case manager (bilingual in patient's language) who reviews all submitted medical records, pelvic floor assessments, and psychological screening reports
• Virtual teleconsultation arranged with the receiving gynecologist and pelvic floor physiotherapist for initial clinical assessment and treatment plan confirmation
• Treatment modality confirmed: behavioral-only program (no sedation required) vs. botulinum toxin injection pathway (requires anesthesia clearance)
• Pre-travel checklist issued: cessation of anticoagulants 7 days before BoNT-A injection, vaginal infection screening results, consent forms
• e-Medical Visa application initiated for India (processing 3–5 business days) or UAE entry visa facilitated
• Accommodation and airport transfer arrangements confirmed

PHASE 2 — ARRIVAL AND INITIAL ASSESSMENT (Day 1–2):